EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Can baseline red blood cell distribution width predict outcomes in peripheral T-cell lymphoma patients?

Yifen Lan, Yanchun Zhao, Jianai Sun, De Zhou, Jinghan Wang, Xiaolong Zheng, Yuanfei Shi, Haitao Meng, Juying Wei, Chunmei Yang, Wenjuan Yu, Jie Jin und 2 weitere

Annals of Hematology · 2026

DOI: 10.1007/s00277-026-06835-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2026. Verfasst von Yifen Lan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, 310003, Zhejiang, Ch…. Hauptthemen laut MEDLINE: Lymphoma, T-Cell, Peripheral, Erythrocyte Indices. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peripheral T-cell lymphoma (PTCL) is a heterogeneous subtype of non-Hodgkin lymphoma with a poor prognosis. Red blood cell distribution width (RDW) is a hematological parameter reflecting variability in erythrocyte volume and has been associated with prognosis in various diseases. Therefore, we conducted a retrospective study on 629 newly diagnosed patients with PTCL to explore the relationship between baseline RDW, prognosis, and response to first-line treatment. The cutoff value for baseline RDW was 14.45%. Patients with baseline RDW ≥ 14.45% had a lower overall response rate than those with RDW < 14.45% (41.98% vs. 78.75%, P < 0.001). Univariate and multivariate logistic regression analyses indicated that baseline RDW ≥ 14.45% was associated with a poorer treatment response. Multivariate Cox analysis identified baseline RDW ≥ 14.45% as an independent prognostic factor in PTCL. Therefore, baseline RDW is an easily accessible and inexpensive marker for prognostic risk stratification in patients with PTCL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, T-Cell, PeripheralErythrocyte IndicesHumansFemaleRetrospective StudiesMaleMiddle AgedAgedPrognosisAdultAged, 80 and overTreatment OutcomeYoung AdultAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

Overall response ratePeripheral t cell lymphomaPrognosisRed blood cell distribution width

Autor:innen und Institutionen

  • Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, 310003, Zhejiang, China.
  • Department of Hematology, Lishui Hospital of Wenzhou Medical University, The First Affiliated Hospital of Lishui University, Lishui People's Hospital, Lishui, 323000, Zhejiang, China.
  • Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, 310003, Zhejiang, China. xiewanzhuo@zju.edu.cn.

Zitieren

APA

Lan, Y., Zhao, Y., Sun, J., Zhou, Wang, J., Zheng, X., Shi, Y., Meng, H., Wei, J., Yang, C., Yu, W., Jin, J., Tong, H., & Xie, W. (2026). Can baseline red blood cell distribution width predict outcomes in peripheral T-cell lymphoma patients?. Annals of Hematology. https://doi.org/10.1007/s00277-026-06835-2

Vancouver

Lan Y, Zhao Y, Sun J, Zhou, Wang J, Zheng X, et al. Can baseline red blood cell distribution width predict outcomes in peripheral T-cell lymphoma patients?. Annals of Hematology. 2026. doi:10.1007/s00277-026-06835-2

BibTeX
@article{Lan2026,
  author = {Lan, Yifen and Zhao, Yanchun and Sun, Jianai and Zhou, De and Wang, Jinghan and Zheng, Xiaolong and Shi, Yuanfei and Meng, Haitao and Wei, Juying and Yang, Chunmei and Yu, Wenjuan and Jin, Jie and Tong, Hongyan and Xie, Wanzhuo},
  title = {Can baseline red blood cell distribution width predict outcomes in peripheral T-cell lymphoma patients?},
  journal = {Annals of Hematology},
  year = {2026},
  doi = {10.1007/s00277-026-06835-2}
}
Kostenlos starten →